ImportRefusal LogoImportRefusal

Reckitt Benckiser Healthcare

⚠️ High Risk

FEI: 3007903677 • Baddi, Himachal Pradesh • INDIA

FEI

FEI Number

3007903677

📍

Location

Baddi, Himachal Pradesh

🇮🇳

Country

INDIA
🏢

Address

No 701/534 Nalagrah Road, , Baddi, Himachal Pradesh, India

High Risk

FDA Import Risk Assessment

60.2
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

20
Total Refusals
7
Unique Violations
5/29/2025
Latest Refusal
6/14/2011
Earliest Refusal

Score Breakdown

Violation Severity
66.6×40%
Refusal Volume
49.0×30%
Recency
87.2×20%
Frequency
14.3×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7511×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

11810×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

164×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

22803×

DIRSEXMPT

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.

32802×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

4711×

CSTIC LBLG

The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.

3351×

LACKS N/C

The article is in package form and appears to not have a label containing an accurate statement of the quantity of the contents in terms of weight, measure or numerical count and no variations or exemptions have been prescribed by regs.

Refusal History

DateProductViolationsDivision
5/29/2025
66VDL99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
Division of West Coast Imports (DWCI)
1/10/2025
62HBL99ANTI-MICROBIAL N.E.C.
118NOT LISTED
Division of West Coast Imports (DWCI)
1/10/2025
62HBO99ANTI-MICROBIAL N.E.C.
118NOT LISTED
Division of West Coast Imports (DWCI)
10/11/2024
66VBY99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
2280DIRSEXMPT
3280FRNMFGREG
75UNAPPROVED
Division of Northeast Imports (DNEI)
9/3/2024
61WBO18MICONAZOLE NITRATE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
118NOT LISTED
2280DIRSEXMPT
Division of Northeast Imports (DNEI)
1/16/2024
61WBJ18MICONAZOLE NITRATE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
118NOT LISTED
2280DIRSEXMPT
Division of Northeast Imports (DNEI)
1/16/2024
66FDG99SUPPRESSANT N.E.C.
75UNAPPROVED
Division of Northeast Imports (DNEI)
10/13/2023
64AAY99DISINFECTANT N.E.C.
75UNAPPROVED
Division of Northeast Imports (DNEI)
11/2/2022
62GDB99ANTI-INFLAMMATORY N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/4/2019
53LC03FACE,BODY,AND HAND (EXCLUDING SHAVING PREPARATIONS) (SKIN CARE PREPARATIONS)
75UNAPPROVED
Division of Northern Border Imports (DNBI)
10/1/2018
61WCJ04CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
118NOT LISTED
3280FRNMFGREG
335LACKS N/C
75UNAPPROVED
Division of Northern Border Imports (DNBI)
12/16/2016
62UBA99ANTI-TUSSIVE/COLD N.E.C.
16DIRECTIONS
Division of Northeast Imports (DNEI)
12/15/2016
62GAJ99ANTI-INFLAMMATORY N.E.C.
118NOT LISTED
75UNAPPROVED
Division of Northern Border Imports (DNBI)
8/11/2014
65QBY99RELAXANT N.E.C.
75UNAPPROVED
Southwest Import District Office (SWI-DO)
3/28/2014
65LBO15ZINC OXIDE PASTE WITH SALICYLIC ACID (PROTECTANT)
16DIRECTIONS
75UNAPPROVED
New England District Office (NWE-DO)
3/28/2014
62GCJ99ANTI-INFLAMMATORY N.E.C.
16DIRECTIONS
75UNAPPROVED
New England District Office (NWE-DO)
4/4/2013
60LBJ99ANALGESIC, N.E.C.
75UNAPPROVED
Southwest Import District Office (SWI-DO)
7/2/2012
60QBJ99ANESTHETIC, N.E.C.
118NOT LISTED
16DIRECTIONS
Division of Northeast Imports (DNEI)
6/26/2012
53LC03FACE,BODY,AND HAND (EXCLUDING SHAVING PREPARATIONS) (SKIN CARE PREPARATIONS)
471CSTIC LBLG
Division of Northeast Imports (DNEI)
6/14/2011
54FBY99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
118NOT LISTED
Cincinnati District Office (CIN-DO)

Frequently Asked Questions

What is Reckitt Benckiser Healthcare's FDA import refusal history?

Reckitt Benckiser Healthcare (FEI: 3007903677) has 20 FDA import refusal record(s) in our database, spanning from 6/14/2011 to 5/29/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Reckitt Benckiser Healthcare's FEI number is 3007903677.

What types of violations has Reckitt Benckiser Healthcare received?

Reckitt Benckiser Healthcare has been cited for 7 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Reckitt Benckiser Healthcare come from?

All FDA import refusal data for Reckitt Benckiser Healthcare is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.